Tianjin Pharmaceutical Da Ren Tang seeks green light for about 586 million Singapore dollars of new guarantees

SGX Filings

Apr 02

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited said on Mar, 30 2026 that it will ask independent shareholders to approve three new guarantees with a combined maximum liability of roughly 585.8 million Singapore dollars.

The company plans to guarantee up to 266.8 million Singapore dollars of bank facilities for Tianjin Pharmaceutical Group Taiping Medicine Co., Ltd.; up to 237.2 million Singapore dollars of bank facilities for Tianjin Zhongxin Medicine Co., Ltd.; and up to 81.8 million Singapore dollars of loans from Tianjin Pharmaceutical Group Finance Co., Ltd. to Tianjin Zhongxin Medicine.

All three counterparties are associates of controlling shareholder Tianjin Pharmaceutical Holdings, making the guarantees interested-person transactions under Singapore Exchange rules. Each facility will be backed jointly and severally by the company and Tianjin Pharmaceutical Holdings in proportion to their 43.35% and 56.65% stakes respectively.

The proposed guarantees represent about 44.2 % of the group’s net tangible assets of 7.0 billion renminbi as at Dec, 31 2025. No counter-guarantees will be obtained. The firm has 418.8 million renminbi of outstanding external guarantees and none are overdue.

Independent shareholders will vote on the resolutions at the annual general meeting scheduled for May, 15 2026. RHB Bank Berhad has been appointed independent financial adviser to opine on the transactions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1188737617"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1188737617\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1188737617?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-02 18:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188737617","market":"sg","top_or_hot":-1,"title":"Tianjin Pharmaceutical Da Ren Tang seeks green light for about 586 million Singapore dollars of new guarantees","media":"SGX Filings","content":"<p>Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited said on Mar, 30 2026 that it will ask independent shareholders to approve three new guarantees with a combined maximum liability of roughly 585.8 million Singapore dollars.</p>\n<p>The company plans to guarantee up to 266.8 million Singapore dollars of bank facilities for Tianjin Pharmaceutical Group Taiping Medicine Co., Ltd.; up to 237.2 million Singapore dollars of bank facilities for Tianjin Zhongxin Medicine Co., Ltd.; and up to 81.8 million Singapore dollars of loans from Tianjin Pharmaceutical Group Finance Co., Ltd. to Tianjin Zhongxin Medicine.</p>\n<p>All three counterparties are associates of controlling shareholder Tianjin Pharmaceutical Holdings, making the guarantees interested-person transactions under Singapore Exchange rules. Each facility will be backed jointly and severally by the company and Tianjin Pharmaceutical Holdings in proportion to their 43.35% and 56.65% stakes respectively.</p>\n<p>The proposed guarantees represent about 44.2 % of the group’s net tangible assets of 7.0 billion renminbi as at Dec, 31 2025. No counter-guarantees will be obtained. The firm has 418.8 million renminbi of outstanding external guarantees and none are overdue.</p>\n<p>Independent shareholders will vote on the resolutions at the annual general meeting scheduled for May, 15 2026. RHB Bank Berhad has been appointed independent financial adviser to opine on the transactions.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tianjin Pharmaceutical Da Ren Tang seeks green light for about 586 million Singapore dollars of new guarantees</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTianjin Pharmaceutical Da Ren Tang seeks green light for about 586 million Singapore dollars of new guarantees\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1083912268\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">SGX Filings </p>\n<p class=\"h-time\">2026-04-02 18:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited said on Mar, 30 2026 that it will ask independent shareholders to approve three new guarantees with a combined maximum liability of roughly 585.8 million Singapore dollars.</p>\n<p>The company plans to guarantee up to 266.8 million Singapore dollars of bank facilities for Tianjin Pharmaceutical Group Taiping Medicine Co., Ltd.; up to 237.2 million Singapore dollars of bank facilities for Tianjin Zhongxin Medicine Co., Ltd.; and up to 81.8 million Singapore dollars of loans from Tianjin Pharmaceutical Group Finance Co., Ltd. to Tianjin Zhongxin Medicine.</p>\n<p>All three counterparties are associates of controlling shareholder Tianjin Pharmaceutical Holdings, making the guarantees interested-person transactions under Singapore Exchange rules. Each facility will be backed jointly and severally by the company and Tianjin Pharmaceutical Holdings in proportion to their 43.35% and 56.65% stakes respectively.</p>\n<p>The proposed guarantees represent about 44.2 % of the group’s net tangible assets of 7.0 billion renminbi as at Dec, 31 2025. No counter-guarantees will be obtained. The firm has 418.8 million renminbi of outstanding external guarantees and none are overdue.</p>\n<p>Independent shareholders will vote on the resolutions at the annual general meeting scheduled for May, 15 2026. RHB Bank Berhad has been appointed independent financial adviser to opine on the transactions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"T14.SI","symbol_name":"达仁堂","start_time":0,"source_url":"","article_id":"1188737617","we_media_id":"1083912268","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188737617","pubTimestamp":1775124856,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"SGX Filings","introduction":"Fastest News on SGX Filings ","home_visible":1,"id":"1083912268","head_image":"https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39"},"summary":"Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited said on Mar, 30 2026 that it will ask independent shareholders to approve three new guarantees with a combined maximum liability of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"T14.SI":"达仁堂"},"translate_title":"天津制药达仁堂寻求约5.86亿新元的新担保","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"T14.SI":1},"content_text":"Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited said on Mar, 30 2026 that it will ask independent shareholders to approve three new guarantees with a combined maximum liability of roughly 585.8 million Singapore dollars.\nThe company plans to guarantee up to 266.8 million Singapore dollars of bank facilities for Tianjin Pharmaceutical Group Taiping Medicine Co., Ltd.; up to 237.2 million Singapore dollars of bank facilities for Tianjin Zhongxin Medicine Co., Ltd.; and up to 81.8 million Singapore dollars of loans from Tianjin Pharmaceutical Group Finance Co., Ltd. to Tianjin Zhongxin Medicine.\nAll three counterparties are associates of controlling shareholder Tianjin Pharmaceutical Holdings, making the guarantees interested-person transactions under Singapore Exchange rules. Each facility will be backed jointly and severally by the company and Tianjin Pharmaceutical Holdings in proportion to their 43.35% and 56.65% stakes respectively.\nThe proposed guarantees represent about 44.2 % of the group’s net tangible assets of 7.0 billion renminbi as at Dec, 31 2025. No counter-guarantees will be obtained. The firm has 418.8 million renminbi of outstanding external guarantees and none are overdue.\nIndependent shareholders will vote on the resolutions at the annual general meeting scheduled for May, 15 2026. RHB Bank Berhad has been appointed independent financial adviser to opine on the transactions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}